{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:44:10Z","timestamp":1790991850984,"version":"4.1.0"},"reference-count":428,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["3 T09A 066 26"],"award-info":[{"award-number":["3 T09A 066 26"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["N204 088 31\/2052 2006-2009"],"award-info":[{"award-number":["N204 088 31\/2052 2006-2009"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015097","name":"Interdyscyplinarne Centrum Modelowania Matematycznego i Komputerowego UW","doi-asserted-by":"publisher","award":["29-15"],"award-info":[{"award-number":["29-15"]}],"id":[{"id":"10.13039\/501100015097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.ejphar.2007.02.038","type":"journal-article","created":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T07:30:58Z","timestamp":1172647858000},"page":"18-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders"],"prefix":"10.1016","volume":"563","author":[{"given":"Dariusz","family":"Pogocki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Ruman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Danilczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Danilczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Celuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Wa\u0142ajtys-Rode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.02.038_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm9506884","article-title":"Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors","volume":"39","author":"Abreo","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1021\/jm00188a009","article-title":"Optically pure (+)-nicotine from (+\/\u2212)-nicotine and biological comparisons with (\u2212)-nicotine","volume":"22","author":"Aceto","year":"1979","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/14622200410001727867","article-title":"Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography\/mass spectrometry and immunoassay test strips","volume":"6","author":"Acosta","year":"2004","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0893-133X(02)00327-5","article-title":"Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats","volume":"27","author":"Addy","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0022-3565(24)36503-6","article-title":"Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function","volume":"280","author":"Albuquerque","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1378\/chest.121.3.932","article-title":"Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation","volume":"121","author":"Anderson","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2007.02.038_bib10","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/np058089f","article-title":"A revised structure for alkaloid 235C isolated from skin extracts of mantellid (Mantella) frogs of Madagascar","volume":"68","author":"Andriamaharavo","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejphar.2007.02.038_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1176\/ajp.149.3.417-b","article-title":"Nicotine gum in Tourette's disorder","volume":"149","author":"Arevalo","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/2261231a0","article-title":"Absorption of nicotine in cigarette and cigar smoke","volume":"226","author":"Armitage","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.02.038_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/(SICI)1520-636X(1998)10:7<587::AID-CHIR6>3.0.CO;2-#","article-title":"Enantiomeric composition of nicotine in smokeless tobacco, medicinal products, and commercial reagents","volume":"10","author":"Armstrong","year":"1998","journal-title":"Chirality"},{"key":"10.1016\/j.ejphar.2007.02.038_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1520-636X(1999)11:1<82::AID-CHIR14>3.0.CO;2-C","article-title":"Enantiomeric composition of nornicotine, anatabine, and anabasine in tobacco","volume":"11","author":"Armstrong","year":"1999","journal-title":"Chirality"},{"key":"10.1016\/j.ejphar.2007.02.038_bib15","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/ac00275a043","article-title":"Determination of nicotine in tobacco by circular dichroism spectropolarimetry","volume":"1084","author":"Atkinson","year":"1984","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib16","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1021\/ie50492a036","article-title":"Solvents for extracting nicotine from aqueous solutions","volume":"43","author":"Badgett","year":"1950","journal-title":"Ind. Eng. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1567205054367838","article-title":"Cholinesterases: roles in the brain during health and disease","volume":"2","author":"Ballard","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.279.5347.77","article-title":"Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors","volume":"279","author":"Bannon","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2007.02.038_bib19","first-page":"206","article-title":"The stereospecificity of nicotine","volume":"25","author":"Barlow","year":"1965","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib20","first-page":"115","article-title":"Addiction and schizophrenia","volume":"15","author":"Batel","year":"2000","journal-title":"Exp. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0166-4328(00)00197-2","article-title":"Central nicotinic receptors, neurotrophic factors and neuroprotection","volume":"113","author":"Belluardo","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib22","series-title":"Research Advances in Alcohol and Drug Problems","article-title":"Human pharmacology of nicotine","author":"Benowitz","year":"1986"},{"key":"10.1016\/j.ejphar.2007.02.038_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0735-1097(02)02819-X","article-title":"Basic cardiovascular research and its implications for the medicinal use of nicotine","volume":"41","author":"Benowitz","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/clpt.1991.165","article-title":"Nicotine metabolism in humans","volume":"50","author":"Benowitz","year":"1991","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/clpt.1993.27","article-title":"Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers","volume":"53","author":"Benowitz","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib28","first-page":"48","article-title":"Individual differences in nicotine kinetics and metabolism in humans","volume":"173","author":"Benowitz","year":"1997","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.ejphar.2007.02.038_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM198307213090303","article-title":"Smokers of low-yield cigarettes do not consume less nicotine","volume":"309","author":"Benowitz","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib30","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/clpt.1983.222","article-title":"Cotinine disposition and effects","volume":"34","author":"Benowitz","year":"1983","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/clpt.1987.119","article-title":"Prolonged absorption with development of tolerance to toxic effects following cutaneous exposure to nicotine","volume":"42","author":"Benowitz","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.HYP.0000018825.76673.EA","article-title":"Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking","volume":"39","author":"Benowitz","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2007.02.038_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/jnci\/94.2.108","article-title":"Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese\u2013Americans","volume":"94","author":"Benowitz","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejphar.2007.02.038_bib29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0022-3565(25)33068-5","article-title":"Interindividual variability in the metabolism and cardiovascular effects of nicotine in man","volume":"221","author":"Benowitz","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib33","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2174\/0929867033456521","article-title":"Muscarinic and nicotinic cholinergic agonists: structural analogies and discrepancies","volume":"10","author":"Bik\u00e1di","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib34","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1021\/jo990152g","article-title":"A novel method for the racemization of 5-bromonicotine","volume":"64","author":"Bleicher","year":"1999","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib35","first-page":"335","article-title":"Free radical damage and oxidative stress in Huntington's disease","volume":"83","author":"Borlongan","year":"1996","journal-title":"J. Fla. Med. Assoc."},{"key":"10.1016\/j.ejphar.2007.02.038_bib36","first-page":"740","article-title":"Determination of nicotine and nornicotine in tobaccos","volume":"15","author":"Bowen","year":"1943","journal-title":"Ind. Eng. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/00397918208065965","article-title":"A convenient method for the preparation of racemic nicotine","volume":"12","author":"Bownam","year":"1982","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejphar.2007.02.038_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbadis.2004.05.007","article-title":"Electrochemical investigation into the redox activity of Fe(II)\/Fe(III) in the presence of nicotine and possible relations to neurodegenerative diseases","volume":"1690","author":"Bridge","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2007.02.038_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/mi.4.5.8","article-title":"Neuronal nicotinic receptor subtypes: defining therapeutic targets","volume":"4","author":"Buccafusco","year":"2004","journal-title":"Mol. Interv."},{"key":"10.1016\/j.ejphar.2007.02.038_bib41","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/S0024-3205(03)00226-1","article-title":"The potential role of cotinine in the cognitive and neuroprotective actions of nicotine","volume":"72","author":"Buccafusco","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib40","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.3233\/JAD-2004-6S612","article-title":"Novel analogs of choline as potential neuroprotective agents","volume":"6","author":"Buccafusco","year":"2004","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2007.02.038_bib42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.18388\/abp.2000_3991","article-title":"Alzheimer's disease: its origin at the membrane, evidence and questions","volume":"47","author":"Buchet","year":"2000","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib43","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1523\/JNEUROSCI.21-06-01819.2001","article-title":"Chronic exposure to nicotine upregulates the human a4b2 nicotinic acetylcholine receptor function","volume":"21","author":"Buisson","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib44","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/jf00018a028","article-title":"Distribution of tobacco constituents in tobacco leaf tissue. 1. Tobacco-specific nitrosamines, nitrate, nitrite, and alkaloids","volume":"40","author":"Burton","year":"1992","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib45","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/1071576021000049890","article-title":"Amyloid b-peptide (1\u201342)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review","volume":"36","author":"Butterfield","year":"2002","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib46","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0196-9781(02)00066-9","article-title":"Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid b-peptide 1\u201342","volume":"23","author":"Butterfield","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2007.02.038_bib47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","article-title":"Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid b-peptide-associated free radical oxidative stress","volume":"32","author":"Butterfield","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0090-9556(25)08565-4","article-title":"Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers","volume":"20","author":"Byrd","year":"1992","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.ejphar.2007.02.038_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1021\/tx00023a003","article-title":"The nitrosation of nicotine: a kinetic study","volume":"4","author":"Caldwell","year":"1991","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib49","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1021\/tx00026a021","article-title":"Characterization of the glucuronide conjugate of cotinine: a previously unidentified major metabolite of nicotine in smokers' urine","volume":"5","author":"Caldwell","year":"1992","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1749-6632.1993.tb39178.x","article-title":"Intragastric nitrosation of nicotine is not a significant contributor to nitrosamine exposure","volume":"686","author":"Caldwell","year":"1993","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib52","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/carcin\/21.4.839","article-title":"Enantiomeric composition of N\u2032-nitrosonornicotine and N\u2032-nitrosoanatabine in tobacco","volume":"21","author":"Carmella","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2007.02.038_bib53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ja0461771","article-title":"Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor","volume":"127","author":"Cashin","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2007.02.038_bib54","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/tx00029a008","article-title":"Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N\u2032-oxide","volume":"5","author":"Cashman","year":"1992","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib55","first-page":"393","article-title":"Nicotine enzyme immunoassay","volume":"51","author":"Castro","year":"1986","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib56","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0896-6273(04)00115-1","article-title":"Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures","volume":"41","author":"Celie","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2007.02.038_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.103.057307","article-title":"Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon","volume":"308","author":"Chadman","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib58","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/jf00079a012","article-title":"Chemical composition of nonsmoking tobacco products","volume":"36","author":"Chamberlain","year":"1988","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib59","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.phytochem.2004.01.019","article-title":"Metabolic fingerprinting of wild type and transgenic tobacco plants by 1H NMR and multivariate analysis technique","volume":"65","author":"Choi","year":"2004","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib60","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1021\/jf990050r","article-title":"Reversed phase ion-pair liquid chromatographic determination of nicotine in commercial tobacco products. 2. Cigarettes","volume":"47","author":"Ciolino","year":"1999","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib61","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1021\/jf990049s","article-title":"Reversed phase ion-pair liquid chromatographic determination of nicotine in commercial tobacco products. 1. Moist snuff","volume":"47","author":"Ciolino","year":"1999","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0021-9673(99)00639-1","article-title":"Optimization study for the reversed-phase ion-pair liquid chromatographic determination of nicotine in commercial tobacco products","volume":"852","author":"Ciolino","year":"1999","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.ejphar.2007.02.038_bib63","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0006-8993(01)02254-5","article-title":"In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation","volume":"900","author":"Cormier","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib64","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0028-3908(03)00041-8","article-title":"Nicotine protects rat brain mitochondria against experimental injuries","volume":"44","author":"Cormier","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib65","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1021\/jm960328w","article-title":"(S)-(\u2212)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors","volume":"39","author":"Cosford","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib66","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0006-8993(00)03087-0","article-title":"Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra","volume":"888","author":"Costa","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0006-3223(00)01116-1","article-title":"Nicotinic receptor abnormalities in Alzheimer's disease","volume":"49","author":"Court","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1039\/AP9832000065","article-title":"Near infrared analysis\u2014today or tomorrow","volume":"20","author":"Cowe","year":"1983","journal-title":"Anal. Proc."},{"key":"10.1016\/j.ejphar.2007.02.038_bib70","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/ja01334a036","article-title":"A new synthesis of nornicotine and nicotine","volume":"55","author":"Craig","year":"1933","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2007.02.038_bib69","series-title":"Modern Pharmacology with Clinical Applications","author":"Craig","year":"1997"},{"key":"10.1016\/j.ejphar.2007.02.038_bib3","series-title":"CRC Handbook of Chemistry and Physics on CD-ROM","year":"2004"},{"key":"10.1016\/j.ejphar.2007.02.038_bib71","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.2042-7158.1988.tb05207.x","article-title":"N-methylation of nicotine enantiomers by human liver cytosol","volume":"40","author":"Crooks","year":"1988","journal-title":"J Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib72","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1021\/ac60106a048","article-title":"Determination of nicotine, nornicotine, and total alkaloids in tobacco","volume":"27","author":"Cundiff","year":"1955","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib73","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0090-9556(25)07793-1","article-title":"Evidence of stereospecificity in the in vivo methylation of [14C](+\/\u2212)-nicotine in the guinea pig","volume":"12","author":"Cundy","year":"1984","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.ejphar.2007.02.038_bib74","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0090-9556(25)08142-5","article-title":"Stereospecific in vivo N-methylation of nicotine in the guinea pig","volume":"13","author":"Cundy","year":"1985","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.ejphar.2007.02.038_bib75","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0033-0620(03)80003-8","article-title":"Cigarette smoking and coronary blood flow","volume":"45","author":"Czernin","year":"2003","journal-title":"Prog. Cardiac. Dis."},{"key":"10.1016\/j.ejphar.2007.02.038_bib76","first-page":"113","article-title":"Involvement of nicotinic acetylcholine receptors in the protection of dopamine terminals in experimental parkinsonism","volume":"16","author":"Dajas","year":"2001","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib77","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1176\/ajp.155.11.1490","article-title":"Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings","volume":"155","author":"Dalack","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib78","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10571-005-3968-4","article-title":"Nicotinic agonists, antagonists, and modulators from natural sources","volume":"25","author":"Daly","year":"2005","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib79","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1021\/np0580560","article-title":"Alkaloids from amphibian skin: a tabulation of over eight-hundred compounds","volume":"68","author":"Daly","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejphar.2007.02.038_bib80","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)35238-3","article-title":"Pharmacological characterization of nicotine-induced seizures in mice","volume":"291","author":"Damaj","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib81","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0091-3057(01)00652-9","article-title":"Cellular mechanisms of nicotine addiction","volume":"70","author":"Dani","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.02.038_bib82","series-title":"Receptor Binding Techniques","author":"Davenport","year":"2005"},{"key":"10.1016\/j.ejphar.2007.02.038_bib83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF01205839","article-title":"The application of Fourier-transformed near-infrared spectra to quantitative analysis by comparison of similarity indices (CARNAC)","volume":"1","author":"Davies","year":"1988","journal-title":"Mikrochim. Acta"},{"key":"10.1016\/j.ejphar.2007.02.038_bib84","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1021\/ie9801958","article-title":"Recovery of nicotine from aqueous extracts of tobacco wastes by an H+-form strong-acid ion exchanger","volume":"37","author":"de Lucas","year":"1998","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib85","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/81566","article-title":"The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy","volume":"26","author":"De","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2007.02.038_bib87","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0006-2952(99)00122-7","article-title":"Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics","volume":"58","author":"Decker","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-3565(24)37015-6","article-title":"ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys","volume":"283","author":"Decker","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib88","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/chir.530050504","article-title":"HPLC separation of the enantiomers of nicotine and nicotine-like compounds","volume":"5","author":"Demetriou","year":"1993","journal-title":"Chirality"},{"key":"10.1016\/j.ejphar.2007.02.038_bib89","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0196-8904(00)00059-5","article-title":"Supercritical fluid extraction and chemicals from biomass with supercritical fluids","volume":"42","author":"Demirbas","year":"2001","journal-title":"Energy Convers. Manag."},{"key":"10.1016\/j.ejphar.2007.02.038_bib90","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1124\/jpet.301.2.594","article-title":"Accelerated metabolism of nicotine and cotinine in pregnant smokers","volume":"301","author":"Dempsey","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib91","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clpt.2004.02.011","article-title":"Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity","volume":"76","author":"Dempsey","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib92","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1128\/aem.39.5.1067-1069.1980","article-title":"Separation of d-(+)-nicotine from a tacemic mixture by stereospecific degradation of the l-(\u2212) isomer with Pseudomonas putida","volume":"39","author":"Detraglia","year":"1980","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib93","series-title":"Medicinal natural products a biosynthetic approach","first-page":"291","article-title":"Alkaloids","author":"Dewick","year":"2002"},{"key":"10.1016\/j.ejphar.2007.02.038_bib94","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jpba.2004.01.009","article-title":"Measuring tobacco smoke exposure: quantifying nicotine\/cotinine concentration in biological samples by colorimetry, chromatography and immunoassay methods","volume":"35","author":"Dhar","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejphar.2007.02.038_bib95","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","article-title":"The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?","volume":"2","author":"Di Monte","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib96","doi-asserted-by":"crossref","first-page":"8182","DOI":"10.1073\/pnas.1332847100","article-title":"Glycation of the amyloid \u03b2-protein by a nicotine metabolite: a fortuitous chemical dynamic between smoking and Alzheimer's disease","volume":"100","author":"Dickerson","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2007.02.038_bib97","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1523\/JNEUROSCI.21-12-04125.2001","article-title":"\u03b2-amyloid activates the mitogen-activated protein kinase cascade via hippocampal \u03b17 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease","volume":"21","author":"Dineley","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib98","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1017\/S0033291796003984","article-title":"Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study","volume":"27","author":"Dursun","year":"1997","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib99","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(94)90388-3","article-title":"Longlasting improvement of Tourette's syndrome with transdermal nicotine","volume":"344","author":"Dursun","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2007.02.038_bib100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.18388\/abp.2000_3989","article-title":"Ion channels-related diseases","volume":"47","author":"Dworakowska","year":"2000","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(95)00077-X","article-title":"Minor alkaloids of tobacco release [3H]dopamine from superfused rat striatal slices","volume":"276","author":"Dwoskin","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib102","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0033-0620(03)80004-X","article-title":"Cigarette smoking and diabetes","volume":"45","author":"Eliasson","year":"2003","journal-title":"Prog. Cardiac. Dis."},{"key":"10.1016\/j.ejphar.2007.02.038_bib103","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.CIR.94.5.878","article-title":"Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance","volume":"94","author":"Eliasson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2007.02.038_bib104","first-page":"41","article-title":"Nicotine and Tourette's syndrome","volume":"23","author":"Erdmann","year":"1996","journal-title":"Psychiatr. Prax."},{"key":"10.1016\/j.ejphar.2007.02.038_bib105","unstructured":"Erhardt, P.W. Drug metabolism-Databases and high-throughput testing during drug design and development. 1999. London, Published for International Union of Pure and Applied Chemistry by Blackwell Science Ltd. Ref Type: Report."},{"key":"10.1016\/j.ejphar.2007.02.038_bib106","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.pbi.2005.09.008","article-title":"Synthesis and trafficking of alkaloid biosynthetic enzymes","volume":"8","author":"Facchini","year":"2005","journal-title":"Curr. Opin. Plant Biol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib107","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.1933.02740210012005","article-title":"Nicotine poisoning by absorption through the skin","volume":"100","author":"Faulkner","year":"1933","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2007.02.038_bib108","first-page":"239","article-title":"Nicotine pharmacokinetics and its application to intake from smoking","volume":"19","author":"Feyerabend","year":"1985","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib109","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1021\/jf950502+","article-title":"Optimization of nicotine extraction from tobacco using supercritical fluid technology with dynamic extraction modeling","volume":"44","author":"Fischer","year":"1996","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.nrl.0000131146.08278.a5","article-title":"Parkinson disease: an update","volume":"10","author":"Frucht","year":"2004","journal-title":"Neurologist"},{"key":"10.1016\/j.ejphar.2007.02.038_bib111","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0306-3623(94)00294-W","article-title":"Inhibitory effects of d-nicotine on the responses evoked by l-isomer in trachea and bronchus isolated from guinea-pig and rabbit","volume":"26","author":"Funayama","year":"1995","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib112","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.2042-7158.1988.tb07004.x","article-title":"Inhibition of histamine N-methyltransferase activity in guinea-pig pulmonary alveolar macrophages by nicotine","volume":"40","author":"Gairola","year":"1988","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib113","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1471-4159.2001.00135.x","article-title":"Nicotine protects against arachidonic-acid-induced caspase activation, cytochrome c release and apoptosis of cultured spinal cord neurons","volume":"76","author":"Garrido","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib114","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0003-2670(98)00387-0","article-title":"Fourier-transform infrared determination of nicotine in tobacco samples by transmittance measurements after leaching with CHCl3","volume":"373","author":"Garrigues","year":"1998","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejphar.2007.02.038_bib115","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0026-895X(25)08622-5","article-title":"Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on tau and mitogen-activated protein kinase","volume":"47","author":"Garver","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib116","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1527-3458.2004.tb00010.x","article-title":"TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects","volume":"10","author":"Gatto","year":"2004","journal-title":"CNS. Drug Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib117","first-page":"480","article-title":"Nicotine absorption by workers harvesting green tobacco","author":"Gehlbach","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2007.02.038_bib118","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0169-409X(02)00149-7","article-title":"Amyloidosis and Alzheimer's disease","volume":"54","author":"Ghiso","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib119","doi-asserted-by":"crossref","first-page":"9245","DOI":"10.1016\/S0040-4039(00)01675-0","article-title":"A short and efficient synthesis of unnatural (R)-nicotine","volume":"41","author":"Girard","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejphar.2007.02.038_bib120","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","article-title":"The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living","volume":"50","author":"Gorell","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib121","series-title":"Analytical Determination of Nicotine and Related Compounds and their Metabolites","author":"Gorrod","year":"1999"},{"key":"10.1016\/j.ejphar.2007.02.038_bib122","series-title":"Analytical Determination of Nicotine and Related Compounds and Their Metabolites","first-page":"45","article-title":"Biotransformation of nicotine in mammalian systems","author":"Gorrod","year":"1999"},{"key":"10.1016\/j.ejphar.2007.02.038_bib123","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1021\/jo035018h","article-title":"The nicotinic pharmacophore: thermodynamics of the hydrogen-bonding complexation of nicotine, nornicotine, and models","volume":"68","author":"Graton","year":"2003","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib124","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.npp.1300102","article-title":"Reversal of a vigilance decrement in the aged rat by subtype-selective nicotinic ligands","volume":"28","author":"Grottick","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2174\/1568026043451177","article-title":"Rational understanding of nicotinic receptors drug binding","volume":"4","author":"Grutter","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib126","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF00053022","article-title":"Nicotine and sympathetic neurotransmission","volume":"10","author":"Haass","year":"1997","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib127","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0883-2897(92)90173-V","article-title":"(S)- and (R)-[11C]nicotine and the metabolite (R\/S)-[11C]cotinine. Preparation, metabolite studies and in vivo distribution in the human brain using PET","volume":"19","author":"Halldin","year":"1992","journal-title":"Int. J. Radiat. Appl. Instrum., B Nucl. Med. Biol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib128","series-title":"Free Radicals in Biology and Medicine","author":"Halliwell","year":"1999"},{"key":"10.1016\/j.ejphar.2007.02.038_bib129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3959(00)00425-5","article-title":"The antinociceptive effect of intrathecal administration of epibatidine with clonidine or neostigmine in the formalin test in rats","volume":"91","author":"Hama","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2007.02.038_bib130","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/sj.npp.1300450","article-title":"Effects of nicotine on cognitive deficits in schizophrenia","volume":"29","author":"Harris","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib131","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/tx980005y","article-title":"Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines","volume":"11","author":"Hecht","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib132","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrc1190","article-title":"Tobacco carcinogens, their biomarkers and tobacco-induced cancer","volume":"3","author":"Hecht","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2007.02.038_bib133","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1021\/ar50135a003","article-title":"Tobacco-specific nitrosamines: occurrence, formation, carcinogenicity, and metabolism","volume":"12","author":"Hecht","year":"1978","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib134","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1073\/pnas.220207697","article-title":"2\u2032-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor","volume":"97","author":"Hecht","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2007.02.038_bib136","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1471-4159.2000.740777.x","article-title":"Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists","volume":"74","author":"Hellstrom-Lindahl","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib135","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1111\/j.0953-816X.2004.03377.x","article-title":"Nicotine reduces A\u03b2 in the brain and cerebral vessels of APPsw mice","volume":"19","author":"Hellstrom-Lindahl","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib137","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.nbd.2003.11.024","article-title":"Reduced levels of A\u03b240 and A\u03b242 in brains of smoking controls and Alzheimer's patients","volume":"15","author":"Hellstrom-Lindahl","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2007.02.038_bib138","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.neuroscience.2004.10.006","article-title":"Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor","volume":"130","author":"Hernandez","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.02.038_bib139","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03188741","article-title":"Enzymology of the metabolic pathway from nicotine to cotinine, in vitro","volume":"8","author":"Hibberd","year":"1983","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2007.02.038_bib140","series-title":"Biological Oxidation of Nitrogen","first-page":"353","article-title":"Detection of nicotine, nicotine-1\u2032-N-oxide and cotinine in maternal and foetal body fluids","author":"Hibberd","year":"1978"},{"key":"10.1016\/j.ejphar.2007.02.038_bib141","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/archinte.1997.00440360143016","article-title":"The nicotine inhaler in smoking cessation","volume":"157","author":"Hjalmarson","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib142","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-3835(85)90174-0","article-title":"Nicotine: a precursor for carcinogens","volume":"26","author":"Hoffmann","year":"1985","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2007.02.038_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10254-003-0005-1","article-title":"Nicotinic acetylcholine receptors: from structure to brain function","volume":"147","author":"Hogg","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib145","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1021\/jm970377o","article-title":"Neuronal nicotinic acetylcholine receptors as targets for drug discovery","volume":"40","author":"Holladay","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib144","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/S0960-894X(98)00504-6","article-title":"Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice","volume":"8","author":"Holladay","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2007.02.038_bib146","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0378-4274(88)90142-7","article-title":"Effect of continuous administration of nicotine on urinary histamine and N tau-methylhistamine levels in the guinea pig","volume":"44","author":"Houdi","year":"1988","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2007.02.038_bib147","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/ac60071a035","article-title":"Separation and determination of nicotine and nornicotine in tobacco","volume":"24","author":"Houston","year":"1952","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/14622416.3.2.185","article-title":"The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence","volume":"3","author":"Howard","year":"2002","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejphar.2007.02.038_bib148","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00008571-200306000-00003","article-title":"CYP2E1\u204e1D regulatory polymorphism: association with alcohol and nicotine dependence","volume":"13","author":"Howard","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ejphar.2007.02.038_bib149","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/sj.bjp.0705146","article-title":"Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics","volume":"138","author":"Howard","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib151","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.eurpsy.2003.11.002","article-title":"Clinical and attentional effects of acute nicotine treatment in Tourette's syndrome","volume":"19","author":"Howson","year":"2004","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib152","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1366\/0003702894204010","article-title":"Fourier transform near-infrared spectrometry: using interferograms to determine chemical composition","volume":"43","author":"Hoy","year":"1989","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.ejphar.2007.02.038_bib153","doi-asserted-by":"crossref","first-page":"37111","DOI":"10.1074\/jbc.274.52.37111","article-title":"Cu(II) potentiation of Alzheimer A\u03b2 neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction","volume":"274","author":"Huang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib154","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.1990.03450120043011","article-title":"Nicotine gum in general practice","volume":"264","author":"Hughes","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2007.02.038_bib155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.57.1.3","article-title":"Metabolism and disposition kinetics of nicotine","volume":"57","author":"Hukkanen","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib156","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0022-3565(25)33223-4","article-title":"The effects of d-nicotine and l-isomer on nicotinic receptors","volume":"222","author":"Ikushima","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib157","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2174\/1568026043387188","article-title":"Cytochromes P450 in the bioactivation of chemicals","volume":"4","author":"Ioannides","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib158","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1021\/jo001442w","article-title":"An immunotherapeutic program for the treatment of nicotine addiction: hapten design and synthesis","volume":"66","author":"Isomura","year":"2005","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib159","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0091-3057(88)90453-4","article-title":"Recent studies of nicotine metabolism in humans","volume":"30","author":"Jacob","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.02.038_bib160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/bmj.328.7434.277","article-title":"Why people smoke","volume":"328","author":"Jarvis","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2007.02.038_bib161","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/00498257309151526","article-title":"The absorption of nicotine-1\u2032-N-oxide and its reduction in the gastro-intestinal tract in man","volume":"3","author":"Jenner","year":"1973","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejphar.2007.02.038_bib162","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0306-4522(01)00488-2","article-title":"Stimulation of non-\u03b17 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture","volume":"109","author":"Jeyarasasingam","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.02.038_bib163","first-page":"38","article-title":"Tau protein in normal and Alzheimer's disease brain","volume":"1","author":"Johnson","year":"1996","journal-title":"Alzheimer's Dis. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib164","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1021\/cr50029a004","article-title":"The chemical constituents of tobacco and tobacco smoke","volume":"59","author":"Johnstone","year":"1959","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/ja00055a002","article-title":"The binding and regioselectivity of reaction of (R)- and (S)-nicotine with cytochrome P-450cam: parallel experimental and theoretical studies","volume":"115","author":"Jones","year":"1993","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2007.02.038_bib166","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0024-3205(01)01529-6","article-title":"Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo","volume":"70","author":"Jonnala","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib167","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.5012\/bkcs.2004.25.12.1959","article-title":"Synthesis and characterization of pseudotetrahedral copper(II) dihalide complexes with (s)-(\u2212)-nicotine","volume":"25","author":"Kang","year":"2004","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.ejphar.2007.02.038_bib169","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0925-4439(01)00097-7","article-title":"Role of glycine-33 and methionine-35 in Alzheimer's amyloid \u03b2-peptide 1\u201342-associated oxidative stress and neurotoxicity","volume":"1586","author":"Kanski","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2007.02.038_bib168","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0891-5849(02)00821-3","article-title":"Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid \u03b2-peptide (1\u201342)","volume":"32","author":"Kanski","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib170","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM198604103141506","article-title":"Alzheimer's disease","volume":"314","author":"Katzman","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib171","first-page":"43","article-title":"The interaction of cigarette smoking and antioxidants. Part III","volume":"8","author":"Kelly","year":"2003","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib172","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0091-3057(01)00651-7","article-title":"Neurobiology of the nicotine withdrawal syndrome","volume":"71","author":"Kenny","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.02.038_bib173","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-3565(25)22349-7","article-title":"Cardiovascular and behavioral responses to nicotinic agents administered intrathecally","volume":"270","author":"Khan","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib174","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-3565(25)22350-3","article-title":"Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine","volume":"270","author":"Khan","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.55782\/ane-2004-1495","article-title":"Alzheimer's disease and acetylcholine receptors","volume":"64","author":"Kihara","year":"2004","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.ejphar.2007.02.038_bib177","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.410420205","article-title":"Nicotinic receptor stimulation protects neurons against \u03b2-amyloid toxicity","volume":"42","author":"Kihara","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib178","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0006-8993(98)00138-3","article-title":"Stimulation of \u03b14\u03b22 nicotinic acetylcholine receptors inhibits \u03b2-amyloid toxicity","volume":"792","author":"Kihara","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib176","doi-asserted-by":"crossref","first-page":"13541","DOI":"10.1074\/jbc.M008035200","article-title":"\u03b17 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A\u03b2-amyloid-induced neurotoxicity","volume":"276","author":"Kihara","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib179","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1749-6632.2001.tb05648.x","article-title":"Oxidative stress and neurodegeneration in prion diseases","volume":"928","author":"Kim","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib180","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1021\/jm980170a","article-title":"2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling","volume":"41","author":"Koren","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib181","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF03033166","article-title":"Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review","volume":"5","author":"Kostrzewa","year":"2003","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib182","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00008571-200106000-00006","article-title":"Nicotine metabolism and CYP2A6 allele frequencies in Koreans","volume":"11","author":"Kwon","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ejphar.2007.02.038_bib183","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molmed.2005.02.009","article-title":"Alzheimer's disease: A\u03b2, tau and synaptic dysfunction","volume":"11","author":"LaFerla","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib186","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0076-6879(82)84050-0","article-title":"Radioimmunoassay of nicotine, cotinine, and gamma-(3-pyridyl)-gamma-oxo-N-methylbutyramide","volume":"84","author":"Langone","year":"1982","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib185","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1021\/bi00748a032","article-title":"Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine","volume":"12","author":"Langone","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib184","series-title":"Analytical Determination of Nicotine and Related Compounds and their Metabolites","first-page":"265","article-title":"Use of immunoassay techniques for the determination of nicotine and its metabolites","author":"Langone","year":"1999"},{"issue":"Suppl 2","key":"10.1016\/j.ejphar.2007.02.038_bib187","first-page":"43","article-title":"Alzheimer disease, attention, and the cholinergic system","volume":"9","author":"Lawrence","year":"1995","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ejphar.2007.02.038_bib188","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1023\/A:1022419712453","article-title":"The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems","volume":"23","author":"Lawrence","year":"1998","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib189","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1098\/rstb.2001.0903","article-title":"The Ligand Gated Ion Channel database: an example of a sequence database in neuroscience","volume":"356","author":"Le","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond., B Biol. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib190","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/neu.10153","article-title":"The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences","volume":"53","author":"Le","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib191","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1073\/pnas.042699699","article-title":"Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites","volume":"99","author":"Le","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2007.02.038_bib192","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neuropharm.2005.10.003","article-title":"CYP2B6 is expressed in African Green monkey brain and is induced by chronic nicotine treatment","volume":"50","author":"Lee","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib193","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0928-4257(98)80140-X","article-title":"Allosteric nicotinic receptors, human pathologies","volume":"92","author":"L\u00e9na","year":"1998","journal-title":"J. Pysiology (Paris)"},{"key":"10.1016\/j.ejphar.2007.02.038_bib194","unstructured":"Leo Corporation. Smoking substitutes and method of production. (Patent GB 1, 325, 011.). 1973. United Kingdom. Ref Type: Patent."},{"key":"10.1016\/j.ejphar.2007.02.038_bib195","series-title":"Receptor Localization Ligand Autoradiography","author":"Leslie","year":"1988"},{"key":"10.1016\/j.ejphar.2007.02.038_bib196","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/neu.10151","article-title":"Nicotinic receptor subtypes and cognitive function","volume":"53","author":"Levin","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(99)00885-7","article-title":"Development of nicotinic drug therapy for cognitive disorders","volume":"393","author":"Levin","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib201","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/1568007023339102","article-title":"Nicotinic treatment for cognitive dysfunction","volume":"1","author":"Levin","year":"2002","journal-title":"Curr. Drug Targets. CNS. Neurol. Disord."},{"key":"10.1016\/j.ejphar.2007.02.038_bib202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0893-133X(96)00018-8","article-title":"Nicotine-haloperidol interactions and cognitive performance in schizophrenics","volume":"15","author":"Levin","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib197","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00008877-199911000-00014","article-title":"AR-R17779, and \u03b17 nicotinic agonist, improves learning and memory in rats","volume":"10","author":"Levin","year":"1999","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib199","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ntt.2005.01.011","article-title":"Olanzapine interactions with nicotine and mecamylamine in rats: effects on memory function","volume":"27","author":"Levin","year":"2005","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib198","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00213-005-0164-7","article-title":"Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization","volume":"184","author":"Levin","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2007.02.038_bib203","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/00498250210128693","article-title":"Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions","volume":"32","author":"Lewis","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejphar.2007.02.038_bib204","doi-asserted-by":"crossref","first-page":"197","DOI":"10.55782\/ane-2002-1438","article-title":"Prion diseases: a dual view of the prion hypothesis as seen from a distance","volume":"62","author":"Liberski","year":"2002","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.ejphar.2007.02.038_bib205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0079-6123(08)60502-6","article-title":"Prenatal adverse effects of nicotine on the developing brain","volume":"73","author":"Lichtensteiger","year":"1988","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib207","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/jm960233u","article-title":"Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties","volume":"40","author":"Lin","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib208","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/jm960233u","article-title":"Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties","volume":"40","author":"Lin","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib206","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/S0960-894X(99)00462-X","article-title":"Structure\u2013activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether framework","volume":"9","author":"Lin","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2007.02.038_bib209","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1196\/annals.1254.007","article-title":"Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology","volume":"998","author":"Lindstrom","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib210","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/sj.bjp.0705653","article-title":"Nicotine attenuates \u03b2-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures","volume":"141","author":"Liu","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib211","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3565(24)35314-5","article-title":"Neuronal nicotinic acetylcholine receptors as novel drug targets","volume":"292","author":"Lloyd","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib212","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3565(24)35314-5","article-title":"Neuronal nicotinic acetylcholine receptors as novel drug targets","volume":"292","author":"Lloyd","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib213","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0022-3565(24)37839-5","article-title":"Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes","volume":"287","author":"Lu","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib214","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-3565(24)35218-8","article-title":"Desensitization of nicotinic agonist-induced [3H]\u03b3-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists","volume":"291","author":"Lu","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/jpme.1982.10.s2.107","article-title":"Nicotine and cotinine\u2014two pharmacologically active substances as parameters for the strain on fetuses and babies of mothers who smoke","volume":"10","author":"Luck","year":"1982","journal-title":"J. Perinat. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib216","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0031-6997(24)01406-6","article-title":"International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits","volume":"51","author":"Lukas","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib217","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0531-5565(00)00112-1","article-title":"Oxidative processes in Alzheimer's disease: the role of A\u03b2-metal interactions","volume":"35","author":"Lynch","year":"2000","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib218","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1021\/jf034807x","article-title":"Solid-state 15N NMR studies of tobacco leaves","volume":"52","author":"Ma","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib219","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clpt.2004.10.011","article-title":"Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence","volume":"77","author":"Malaiyandi","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib220","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-3565(24)36534-6","article-title":"Nicotine-induced inhibition of neuronal phospholipase A2","volume":"280","author":"Marin","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib221","doi-asserted-by":"crossref","first-page":"81","DOI":"10.55782\/ane-2004-1493","article-title":"Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease","volume":"64","author":"Marlatt","year":"2004","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.ejphar.2007.02.038_bib222","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1471-4159.2001.00056.x","article-title":"Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction","volume":"76","author":"Matarredona","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib223","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00252173","article-title":"Nicotine-11C: synthesis and distribution kinetics in animals","volume":"1","author":"Maziere","year":"1976","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib224","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1360-0443.2002.00064.x","article-title":"Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?","volume":"97","author":"McChargue","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2007.02.038_bib225","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1366\/0003702844555449","article-title":"Fourier analysis enhances NIR diffuse reflectance spectroscopy","volume":"38","author":"McClure","year":"1984","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.ejphar.2007.02.038_bib226","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/0006-3223(92)90315-Q","article-title":"The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder","volume":"31","author":"McConville","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib227","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/1568007023339210","article-title":"The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome","volume":"1","author":"McEvoy","year":"2002","journal-title":"Curr. Drug Targets. CNS. Neurol. Disord."},{"key":"10.1016\/j.ejphar.2007.02.038_bib228","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02246063","article-title":"Haloperidol increases smoking in patients with schizophrenia","volume":"119","author":"McEvoy","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2007.02.038_bib229","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002130050991","article-title":"Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats","volume":"144","author":"McGaughy","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2007.02.038_bib230","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0021-9258(18)81325-4","article-title":"N-methylation of nicotine ad cotinine in vivo","volume":"238","author":"McKennis","year":"1963","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib231","first-page":"283","article-title":"Aluminium, amyloid, and Alzheimer's disease","volume":"48","author":"Mera","year":"1991","journal-title":"Med. Lab. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib232","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0022-3565(24)36947-2","article-title":"A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes","volume":"282","author":"Messina","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib233","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1021\/cr020443g","article-title":"Mechanism of oxidation reactions catalyzed by cytochrome P450 enzymes","volume":"104","author":"Meunier","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib234","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0188-4409(99)00087-9","article-title":"Nicotine, brain nicotinic receptors, and neuropsychiatric disorders","volume":"31","author":"Mihailescu","year":"2000","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib236","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1139\/jpn.0261","article-title":"Drug-metabolizing cytochrome P450s in the brain","volume":"27","author":"Miksys","year":"2002","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib235","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0006-2952(00)00281-1","article-title":"Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment","volume":"59","author":"Miksys","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib237","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1021\/ie00024a014","article-title":"Countercurrent extraction of nicotine from tobacco juice","volume":"32","author":"Millen","year":"1993","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib238","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1021\/ie00036a044","article-title":"Distribution coefficients of nicotine between hexane and water","volume":"33","author":"Millen","year":"1994","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib239","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0301-0082(00)00015-0","article-title":"The role of oxidative stress in the toxicity induced by amyloid \u03b2-peptide in Alzheimer's disease","volume":"62","author":"Miranda","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib240","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0041-008X(75)90255-0","article-title":"Formation of N-nitroso compounds: chemistry, kinetics, and in vivo occurrence","volume":"31","author":"Mirvish","year":"1975","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib241","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1021\/bi035728h","article-title":"Both the d-(+) and l-(\u2212) enatiomers of nicotine inhibit A\u03b2 aggregation and cytotoxicity","volume":"43","author":"Moore","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib242","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0021-9673(01)95514-1","article-title":"High-performance liquid chromatography with electrochemical detection for the determination of nicotine and N-methylnicotinium ion","volume":"347","author":"Mousa","year":"1985","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ejphar.2007.02.038_bib243","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0021-9258(19)44077-5","article-title":"Enzymatic oxidation of nicotine to nicotine \u03941\u2032(5\u2032) Iminium Ion. A newly discovered intermediate the matabolism of nicotine","volume":"248","author":"Murphy","year":"1973","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib247","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0022-3565(25)12887-5","article-title":"Characterization of CYP2A6 involved in 3\u2032-hydroxylation of cotinine in human liver microsomes","volume":"277","author":"Nakajima","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib248","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0090-9556(25)08453-3","article-title":"Role of human cytochrome P4502A6 in C-oxidation of nicotine","volume":"24","author":"Nakajima","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2007.02.038_bib246","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1067\/mcp.2000.103957","article-title":"Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans","volume":"67","author":"Nakajima","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib245","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/mcp.2001.112688","article-title":"Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans","volume":"69","author":"Nakajima","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib244","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/abio.2001.5528","article-title":"High-performance liquid chromatographic assay for N-glucuronidation of nicotine and cotinine in human liver microsomes","volume":"302","author":"Nakajima","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib249","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0741-8329(01)00150-1","article-title":"Nicotinic acetylcholine receptors and neurodegenerative disease","volume":"24","author":"Nakamura","year":"2001","journal-title":"Alcohol"},{"key":"10.1016\/j.ejphar.2007.02.038_bib250","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0006-3223(00)01069-6","article-title":"Nicotinic treatment of Alzheimer's disease","volume":"49","author":"Newhouse","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib251","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/S0024-3205(02)02135-5","article-title":"Nicotine's oxidative and antioxidant properties in CNS","volume":"71","author":"Newman","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib252","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0021-9673(03)01178-6","article-title":"Effects of moisture content in cigar tobacco on nicotine extraction. Similarity between Soxhlet and focused open-vessel microwave-assisted techniques","volume":"1011","author":"Ng","year":"2003","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.ejphar.2007.02.038_bib253","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0773.1995.tb00123.x","article-title":"Nicotine dependence, midbrain dopamine systems and psychiatric disorders","volume":"76","author":"Nisell","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib2","series-title":"New Delhi, Technology Information, Forecasting & Assessment Council (TIFAC)","article-title":"Nicotine and its derivatives from tobacco waste","year":"2000"},{"key":"10.1016\/j.ejphar.2007.02.038_bib254","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0166-4328(00)00204-7","article-title":"Role of \u03b17 nicotinic receptors in nicotine dependence and implications for psychiatric illness","volume":"113","author":"Nomikos","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib257","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0166-4328(93)90138-G","article-title":"Clinical studies in Alzheimer patients with positron emission tomography","volume":"57","author":"Nordberg","year":"1993","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib255","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0197-0186(94)90059-0","article-title":"Human nicotinic receptors\u2014their role in aging and dementia","volume":"25","author":"Nordberg","year":"1994","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2007.02.038_bib256","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-3223(00)01125-2","article-title":"Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications","volume":"49","author":"Nordberg","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib258","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02248669","article-title":"Uptake and regional distribution of (+)-(R)- and (\u2212)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo","volume":"1","author":"Nordberg","year":"1989","journal-title":"J. Neural Transm., Parkinson's Dis. Dement. Sect."},{"key":"10.1016\/j.ejphar.2007.02.038_bib259","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1471-4159.2002.00874.x","article-title":"Chronic nicotine treatment reduces \u03b2-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)","volume":"81","author":"Nordberg","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/ie50362a019","article-title":"Distribution of nicotine between water and petroleum oils","volume":"32","author":"Norton","year":"1940","journal-title":"Ind. Eng. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib261","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3109\/00498258809042260","article-title":"Species variation and stereoselectivity in the metabolism of nicotine enantiomers","volume":"18","author":"Nwosu","year":"1988","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejphar.2007.02.038_bib262","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.2042-7158.1988.tb06289.x","article-title":"Enantioselective metabolism during continuous administration of S-(\u2212)- and R-(+)-nicotine isomers to guinea-pigs","volume":"40","author":"Nwosu","year":"1988","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib263","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2174\/1568007023339166","article-title":"The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration","volume":"1","author":"O'Neill","year":"2002","journal-title":"Curr. Drug Targets. CNS. Neurol. Disord."},{"key":"10.1016\/j.ejphar.2007.02.038_bib264","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0090-9556(25)08548-4","article-title":"Radioimmunoassay of nicotine-delta 1\u2032(5\u2032)-iminium ion, an intermediate formed during the metabolism of nicotine to cotinine","volume":"18","author":"Obach","year":"1990","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2007.02.038_bib265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0304-3940(02)00737-1","article-title":"Nicotine suppresses 1-methyl-4-phenylpyridinium ion-induced hydroxyl radical generation in rat striatum","volume":"330","author":"Obata","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.02.038_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphysparis.2005.12.080","article-title":"The role of nicotinic acetylcholine receptors in Alzheimer's disease","author":"Oddo","year":"2006","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.ejphar.2007.02.038_bib266","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1073\/pnas.0408500102","article-title":"Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease","volume":"102","author":"Oddo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2007.02.038_bib268","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1073\/pnas.90.1.307","article-title":"Blood\u2013brain barrier penetration abolished by N-methyl quaternization of nicotine","volume":"90","author":"Oldendorf","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2007.02.038_bib269","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3181\/00379727-147-38444","article-title":"Lipid solubility and drug penetration in the blood\u2013brain barrier","volume":"147","author":"Olendorf","year":"1974","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.bdj.4813187","article-title":"Nicotine, smoke and patches","volume":"200","author":"Palmer","year":"2006","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.ejphar.2007.02.038_bib271","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0022-3565(24)29581-1","article-title":"Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes","volume":"297","author":"Papke","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib272","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/tx00036a019","article-title":"Stereoselective metabolism of (S)-(\u2212)-nicotine in humans: formation of trans-(S)-(\u2212)-nicotine N-1\u2032-oxide","volume":"6","author":"Park","year":"1993","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib273","series-title":"Casarett and Doull's toxicology the basic science of poisons","first-page":"133","article-title":"Biotransformation of xenobiotics","author":"Parkinson","year":"2001"},{"key":"10.1016\/j.ejphar.2007.02.038_bib274","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Paterson","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib275","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1196\/annals.1332.019","article-title":"Nicotinic receptor modulation for neuroprotection and enhancement of functional recovery following brain injury or disease","volume":"1035","author":"Pauly","year":"2004","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib276","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00043764-199501000-00004","article-title":"Individual expression of carcinogen-metabolizing enzymes: cytochrome P4502A","volume":"37","author":"Pelkonen","year":"1995","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib277","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0026-895X(25)09730-5","article-title":"Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover","volume":"46","author":"Peng","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib278","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/jm00398a024","article-title":"Regio- and stereochemical studies on the \u03b1-carbon oxidation of (S)-nicotine by cytochrome P-450 model systems","volume":"31","author":"Peterson","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib279","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1021\/jm00385a004","article-title":"Stereochemical studies on the cytochrome P-450 catalyzed oxidation of (S)-nicotine to the (S)-nicotine \u03941\u2032(5\u2032)-iminium species","volume":"30","author":"Peterson","year":"1987","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib280","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1080\/01483918008062792","article-title":"Chemical studies on tobacco smoke LXVII. Quantitative determination of alkaloids in tobacco by liquid chromatography","volume":"3","author":"Piade","year":"1980","journal-title":"J. Liq. Chromatogr."},{"key":"10.1016\/j.ejphar.2007.02.038_bib281","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/31623","article-title":"Nicotine metabolism defect reduces smoking","volume":"393","author":"Pianezza","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2007.02.038_bib282","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0893-133X(99)00146-3","article-title":"Nicotinic receptors in the brain: links between molecular biology and behavior","volume":"22","author":"Piccotto","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib283","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/neu.10102","article-title":"Nicotinic receptors in aging and dementia","volume":"53","author":"Piccotto","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib284","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0009-8981(93)90160-6","article-title":"Comparison of a mechanized version of the \u2018Konig\u2019 reaction and a fluorescence polarization immunoassay for the determination of nicotine metabolites in urine","volume":"217","author":"Pickert","year":"1993","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2007.02.038_bib285","first-page":"230","article-title":"Cigarette smoking, endothelial injury and cardiovascular disease","volume":"81","author":"Pittilo","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib286","doi-asserted-by":"crossref","first-page":"131","DOI":"10.55782\/ane-2003-1463","article-title":"Alzheimer's \u03b2-amyloid peptide as a source of neurotoxic free radicals: the role of structural effects","volume":"63","author":"Pogocki","year":"2003","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.ejphar.2007.02.038_bib287","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1021\/tx030044w","article-title":"Mutation of the Phe20 residue in Alzheimer's amyloid (-peptide might decrease its toxicity due to disruption of the Met35-cupric site electron-transfer pathway","volume":"17","author":"Pogocki","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib288","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0090-9556(25)08253-4","article-title":"Biotransformation of primary nicotine metabolites. I. In vivo metabolism of R-(+)-[14C-NCH3]N-methylnicotinium ion in the guinea pig","volume":"13","author":"Pool","year":"1985","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2007.02.038_bib289","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.2042-7158.1988.tb05167.x","article-title":"Biotransformation of primary nicotine metabolites: metabolism of R-(+)-[3H-N\u2032-CH3; 14C-N-CH3] N-methylnicotinium acetate\u2014the use of double isotope studies to determine the in-vivo stability of the N-methyl groups of N-methylnicotinium ion","volume":"40","author":"Pool","year":"1988","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib290","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s002130050897","article-title":"Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease","volume":"142","author":"Potter","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2007.02.038_bib291","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s002130050538","article-title":"Central nicotinic receptor agonists ABT-418, ABT-089, and (\u2212)-nicotine reduce distractibility in adult monkeys","volume":"136","author":"Prendergast","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2007.02.038_bib292","first-page":"CD004838","article-title":"Nicotine for schizophrenia","author":"Punnoose","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib293","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/neu.10109","article-title":"Desensitization of neuronal nicotinic receptors","volume":"53","author":"Quick","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib294","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tins.2004.06.008","article-title":"Smoking, nicotine and Parkinson's disease","volume":"27","author":"Quik","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib295","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0006-8993(01)02937-7","article-title":"Nicotine administration reduces striatal MPP+ levels in mice","volume":"917","author":"Quik","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib296","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1124\/jpet.105.094375","article-title":"Striatal \u03b16\u204e nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy","volume":"316","author":"Quik","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib297","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2003.12.038","article-title":"Pharmacological characterization of SIB-1663, a conformationally rigid analog of nicotine","volume":"1003","author":"Rao","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib298","first-page":"360","article-title":"Plant NMR spectroscopy","volume":"39","author":"Ratcliffe","year":"2001","journal-title":"Prog. NMR Spectrosc."},{"key":"10.1016\/j.ejphar.2007.02.038_bib299","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-3223(00)01047-7","article-title":"Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease","volume":"49","author":"Rattray","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib300","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1089\/neu.2005.22.240","article-title":"Nicotine attenuates morphological deficits in a contusion model of spinal cord injury","volume":"22","author":"Ravikumar","year":"2005","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejphar.2007.02.038_bib301","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0006-3223(00)01094-5","article-title":"Cognitive effects of nicotine","volume":"49","author":"Rezvani","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib303","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0006-3223(00)01094-5","article-title":"Cognitive effects of nicotine","volume":"49","author":"Rezvani","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib304","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2003.12.021","article-title":"Nicotine-antipsychotic drug interactions and attentional performance in female rats","volume":"486","author":"Rezvani","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib302","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pnpbp.2005.10.017","article-title":"Chronic nicotine interactions with clozapine and risperidone and attentional function in rats","volume":"30","author":"Rezvani","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib305","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1176\/ajp.149.3.417b","article-title":"Nicotine gum in Tourette's disorder","volume":"149","author":"Rickards","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib306","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0022-3565(25)24616-X","article-title":"Effects of the stereoisomers of nicotine and nornicotine on schedule-controlled responding and physiological parameters of dogs","volume":"244","author":"Risner","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib307","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1046\/j.1471-4159.2001.00088.x","article-title":"Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum","volume":"76","author":"Roceri","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib308","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/clpt.1980.196","article-title":"Disposition kinetics and effects of intravenous nicotine","volume":"28","author":"Rosenberg","year":"1980","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib309","unstructured":"Ross, A.B., Mallard, W.G., Helman, W.P., Bielski, B.H.J., Buxton, G.V., Cabelli, D.E., Greenstock, C.L., Huie, R.E., and Neta, P. NDRL-NIST Solution Kinetics Database- Ver. 1. 1. 1992. Gaithersburg, MD., NIST Standard Reference Data. Ref Type: Generic."},{"key":"10.1016\/j.ejphar.2007.02.038_bib310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mehy.2004.08.031","article-title":"Alzheimer's disease and the \u2018ABSENT\u2019 hypothesis: mechanism for amyloid \u03b2 endothelial and neuronal toxicity","volume":"65","author":"Roy","year":"2005","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2007.02.038_bib312","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1136\/bmj.280.6231.1599","article-title":"Clinical use of nicotine chewing gum","volume":"280","author":"Russell","year":"1980","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2007.02.038_bib311","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/bmj.283.6295.814","article-title":"Nicotine intake by snuff users","volume":"283","author":"Russell","year":"1981","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2007.02.038_bib313","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/sj.bjp.0703989","article-title":"Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in \u03b14 nicotinic receptor subunit knockout mice","volume":"132","author":"Ryan","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib314","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s007020050090","article-title":"Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease","volume":"105","author":"Sabbagh","year":"1998","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2007.02.038_bib315","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3565(25)12301-X","article-title":"Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats","volume":"276","author":"Sacaan","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib316","series-title":"Physics and chemistry basis of biotechnology","article-title":"Rational design of P450 enzymes for biotechnology","author":"Sadeghi","year":"2001"},{"key":"10.1016\/j.ejphar.2007.02.038_bib317","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1021\/bi9617264","article-title":"Nicotine inhibits amyloid formation by the \u03b2-peptide","volume":"35","author":"Salomon","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib318","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(96)00199-4","article-title":"Nicotine for the treatment of Tourette's syndrome","volume":"74","author":"Sanberg","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib319","doi-asserted-by":"crossref","first-page":"51307","DOI":"10.1074\/jbc.M307797200","article-title":"Characterization of HdnoR, the transcriptional repressor of the 6-hydroxy-d-nicotine oxidase gene of Arthrobacter nicotinovorans pAO1, and its DNA-binding activity in response to l- and d-nicotine derivatives","volume":"278","author":"Sandu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib320","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/cr60233a003","article-title":"Ultra violet spectra of alkaloids","volume":"65","author":"Sangster","year":"1965","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib321","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0021-9673(00)81822-1","article-title":"Quantitation of major tobacco alkaloids by high-performance liquid chromatography","volume":"205","author":"Saunders","year":"1981","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.ejphar.2007.02.038_bib322","first-page":"495","article-title":"Suicide plan by nicotine poisoning: a review of nicotine toxicity","volume":"27","author":"Saxena","year":"1985","journal-title":"Vet. Human Toxicol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib323","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6807-2-1","article-title":"Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine","volume":"2","author":"Schapira","year":"2002","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib324","first-page":"245","article-title":"Absorption of nicotine through the oral mucosa. I. Measurement of nicotine concentration in the blood after application of nicotine and total particulate matter","volume":"3","author":"Schievelbein","year":"1973","journal-title":"Agents Actions"},{"key":"10.1016\/j.ejphar.2007.02.038_bib325","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/cr60307a001","article-title":"Nitrogen-containing compounds in tobacco and tobacco smoke","volume":"77","author":"Schmeltz","year":"1977","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib326","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1749-6632.1967.tb13708.x","article-title":"Distribution of nicotine in the central nervous system","volume":"142","author":"Schmiterlow","year":"1967","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib329","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/j.1360-0443.1995.tb02837.x","article-title":"Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial","volume":"90","author":"Schneider","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2007.02.038_bib328","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00003088-199631010-00005","article-title":"Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems","volume":"31","author":"Schneider","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2007.02.038_bib330","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1360-0443.1996.tb03616.x","article-title":"Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial","volume":"91","author":"Schneider","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2007.02.038_bib327","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-3565(24)34957-2","article-title":"Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys","volume":"290","author":"Schneider","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib331","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbapap.2004.09.009","article-title":"Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease","volume":"1703","author":"Schoneich","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2007.02.038_bib332","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/abbi.2001.2621","article-title":"Redox processes of methionine relevant to \u03b2-amyloid oxidation and Alzheimer's disease","volume":"397","author":"Sch\u00f6neich","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2007.02.038_bib333","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF01929348","article-title":"Alzheimer's disease: fundamental and therapeutic aspects","volume":"51","author":"Schorderet","year":"1995","journal-title":"Experientia"},{"key":"10.1016\/j.ejphar.2007.02.038_bib334","first-page":"674","article-title":"Transdermal nicotine treatment of ulcerative colitis: a survey of a Cochrane review","volume":"168","author":"Seidelin","year":"2006","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.ejphar.2007.02.038_bib335","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1359-6446(03)02704-1","article-title":"Decreasing smoking behaviour and risk through CYP2A6 inhibition","volume":"8","author":"Sellers","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2007.02.038_bib336","first-page":"1","article-title":"Neuronal nicotinic receptors","volume":"19","author":"Sharples","year":"2001","journal-title":"Tocris Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib337","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.aca.2006.01.002","article-title":"Determination of tobacco alkaloids by gas chromatography\u2013mass spectrometry using cloud point extraction as a preconcentration step","volume":"561","author":"Shen","year":"2006","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejphar.2007.02.038_bib338","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1517\/17425247.2.3.563","article-title":"Nicotine delivery systems","volume":"2","author":"Shiffman","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejphar.2007.02.038_bib339","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/fpj.84.1","article-title":"Pharmacodynamic effects of d-nicotine\u2014comparison with l-nicotine","volume":"84","author":"Shimada","year":"1984","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"10.1016\/j.ejphar.2007.02.038_bib340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/fpj.84.1","article-title":"Pharmacodynamic effects of d-nicotine\u2014comparison with l-nicotine","volume":"84","author":"Shimada","year":"1984","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"10.1016\/j.ejphar.2007.02.038_bib341","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1749-6632.1996.tb34445.x","article-title":"Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation","volume":"777","author":"Shimohama","year":"1996","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib342","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1098-2299(199607\/08)38:3\/4<290::AID-DDR18>3.0.CO;2-2","article-title":"Transdermal nicotine for Tourette's syndrome","volume":"38","author":"Shytle","year":"1996","journal-title":"Drug. Dev. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib343","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1073191103255497","article-title":"The Tourette's Disorder Scale (TODS): development, reliability, and validity","volume":"10","author":"Shytle","year":"2003","journal-title":"Assessment"},{"key":"10.1016\/j.ejphar.2007.02.038_bib344","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7326\/0003-4819-138-8-200304150-00013","article-title":"Update on Parkinson disease","volume":"138","author":"Siderowf","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib345","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1046\/j.1471-4159.1999.0731264.x","article-title":"Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain","volume":"73","author":"Sihver","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib346","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0969-8051(99)00034-7","article-title":"In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(\u2212)[11C]nicotine in rhesus monkeys","volume":"26","author":"Sihver","year":"1999","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib347","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0306-4522(99)00295-X","article-title":"Autoradiographic comparison of [3H](\u2212)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease","volume":"94","author":"Sihver","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2007.02.038_bib348","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0166-4328(00)00209-6","article-title":"Development of ligands for in vivo imaging of cerebral nicotinic receptors","volume":"113","author":"Sihver","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib349","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.coph.2005.01.014","article-title":"Acetylcholinesterase: \u2018classical\u2019 and \u2018non-classical\u2019 functions and pharmacology","volume":"5","author":"Silman","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib350","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0140-6736(93)91392-Y","article-title":"Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome","volume":"342","author":"Silver","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2007.02.038_bib354","first-page":"402","article-title":"Multiple nicotine binding sites in rat brain P2 fraction","volume":"19","author":"Sloan","year":"1983","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.ejphar.2007.02.038_bib355","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0091-3057(84)90015-7","article-title":"Nature of nicotine binding to rat brain P2 fraction","volume":"20","author":"Sloan","year":"1984","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.02.038_bib352","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0091-3057(85)90105-4","article-title":"Binding characteristics of (\u2212)- and (+)-nicotine to the rat brain P2 fraction","volume":"23","author":"Sloan","year":"1985","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.02.038_bib353","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/jm00147a021","article-title":"Structure\u2013activity relationships of some pyridine, piperidine, and pyrrolidine analogues for enhancing and inhibiting the binding of (+\/\u2212)-[3H]nicotine to the rat brain P2 preparation","volume":"28","author":"Sloan","year":"1985","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib351","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0091-3057(88)90454-6","article-title":"The comparative binding characteristics of nicotinic ligands and their pharmacology","volume":"30","author":"Sloan","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.02.038_bib356","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(00)00040-5","article-title":"Oxidative stress in Alzheimer's disease","volume":"1502","author":"Smith","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2007.02.038_bib357","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.npp.1300881","article-title":"Effects of nicotine nasal spray on cognitive function in schizophrenia","volume":"31","author":"Smith","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib358","doi-asserted-by":"crossref","first-page":"53","DOI":"10.55782\/ane-2004-1491","article-title":"Amyloid-\u03b2 and tau proteins as biochemical markers of Alzheimer's disease","volume":"64","author":"Sobow","year":"2004","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.ejphar.2007.02.038_bib359","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0006-2952(02)01070-5","article-title":"Effects of (\u2212)-nicotine and (\u2212)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease","volume":"64","author":"Soto-Otero","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib360","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1021\/ja00035a048","article-title":"Epibatidine: a novel (Chloropyridyl)azabicycloheptane with potent analgesic activity from an ecuadoran poison frog","volume":"114","author":"Spande","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2007.02.038_bib361","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1471-4159.1982.tb08669.x","article-title":"Active transport of nicotine by the isolated choroid plexus in vitro","volume":"38","author":"Spector","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib362","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0920-9964(01)00187-6","article-title":"Smoking in schizophrenia \u2014 all is not biological","volume":"56","author":"Srinvasan","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib363","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1748-1716.1970.tb04786.x","article-title":"Effects of increased liver metabolism of nicotine on its uptake, elimination and toxicity in mice","volume":"80","author":"Stalhandske","year":"1970","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejphar.2007.02.038_bib364","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1021\/cr60252a002","article-title":"The chemical composition of tobacco and tobacco smoke","volume":"68","author":"Stedman","year":"1968","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib365","doi-asserted-by":"crossref","first-page":"11943","DOI":"10.1021\/bi034833o","article-title":"Crystallographic studies on the complex behavior of nicotine binding to P450cam (CYP101)","volume":"42","author":"Strickler","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2007.02.038_bib366","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1081\/AL-200065801","article-title":"Electrochemical behavior of nicotine studied by voltammetric techniques at boron-doped diamond electrodes","volume":"38","author":"Suffredini","year":"2005","journal-title":"Ann. Lett."},{"key":"10.1016\/j.ejphar.2007.02.038_bib367","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)37014-4","article-title":"ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties","volume":"283","author":"Sullivan","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib368","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1520-636X(1998)10:4<364::AID-CHIR13>3.0.CO;2-Y","article-title":"Separation of nicotine and nornicotine enantiomers via normal phase HPLC on derivatized cellulose chiral stationary phases","volume":"10","author":"Tang","year":"1998","journal-title":"Chirality"},{"key":"10.1016\/j.ejphar.2007.02.038_bib369","doi-asserted-by":"crossref","first-page":"L91","DOI":"10.1016\/0024-3205(94)00653-9","article-title":"Nicotine stimulation of nerve growth factor receptor expression","volume":"55","author":"Terry","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib370","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1527-3458.2005.tb00045.x","article-title":"Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition","volume":"11","author":"Terry","year":"2005","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib371","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0306-3623(92)90149-E","article-title":"Selected biological activities of novel selenonium choline analogs","volume":"23","author":"Terry","year":"1992","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib1","series-title":"Atlanta, Georgia: U. S., U. S. Department of Health and Human Services. Office on Smoking and Health","article-title":"The health consequences of smoking-nicotine addiction: a report of the surgeon general","year":"1988"},{"key":"10.1016\/j.ejphar.2007.02.038_bib372","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s002130050885","article-title":"Dose-dependent stereoselective activation of the trigeminal sensory system by nicotine in man","volume":"142","author":"Thuerauf","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2007.02.038_bib373","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00004714-200008000-00012","article-title":"Specific sensory detection, discrimination, and hedonic estimation of nicotine enantiomers in smokers and nonsmokers: are there limitations in replacing the sensory components of nicotine?","volume":"20","author":"Thuerauf","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib374","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/0929867013373165","article-title":"Agonists at the \u03b14\u03b22 nicotinic acetylcholine receptors: structure\u2013activity relationships and molecular modelling","volume":"8","author":"Tonder","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib375","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-3565(24)38944-X","article-title":"Modulation of nitric-oxide synthase by nicotine","volume":"295","author":"Tonnessen","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib376","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.1960.tb32612.x","article-title":"Absorption of nicotine from various sites","volume":"90","author":"Travell","year":"1960","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib377","doi-asserted-by":"crossref","first-page":"41","DOI":"10.55782\/ane-2004-1490","article-title":"Neurodegenerative aspects of protein aggregation","volume":"64","author":"Trzesniewska","year":"2004","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.ejphar.2007.02.038_bib378","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(02)01254-5","article-title":"Copper-dependent generation of hydrogen peroxide from the toxic prion protein fragment PrP106-126","volume":"336","author":"Turnbull","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2007.02.038_bib379","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/00498257509056124","article-title":"Metabolism of nicotine by the isolated perfused dog lung","volume":"5","author":"Turner","year":"1975","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejphar.2007.02.038_bib380","first-page":"143","article-title":"Pharmacokinetics and metabolism of nicotine","volume":"57","author":"Tutka","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2007.02.038_bib381","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00007691-200202000-00026","article-title":"Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior","volume":"24","author":"Tyndale","year":"2002","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2007.02.038_bib382","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1360-0443.2005.01014.x","article-title":"Nicotine analogues: a review of tobacco industry research interests","volume":"100","author":"Vagg","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2007.02.038_bib383","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0002-9378(74)90180-X","article-title":"Nicotine and cotinine in the amniotic fluid of smokers in the second trimester of pregnancy","volume":"120","author":"Van Vunakis","year":"1974","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib384","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-003-1668-7","article-title":"AR-R 17779 improves social recognition in rats by activation of nicotinic \u03b17 receptors","volume":"172","author":"Van","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2007.02.038_bib385","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0076-6879(80)70049-6","article-title":"Radioimmunoassays: an overview","volume":"70","author":"Van","year":"1980","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib386","first-page":"293","article-title":"Radioimmunoassay for nicotine and cotinine","author":"Van","year":"1993","journal-title":"IARC Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib387","first-page":"317","article-title":"Radioimmunoassay for nicotine and cotinine","author":"Van","year":"1987","journal-title":"IARC Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib388","first-page":"95","article-title":"Near-infrared reflectance measurement of total nicotine content of tobacco","volume":"21","author":"Vardi","year":"1992","journal-title":"Acta Aliment."},{"key":"10.1016\/j.ejphar.2007.02.038_bib389","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0960-894X(98)00394-1","article-title":"Conformationally restricted analogues of nicotine and anabasine","volume":"8","author":"Vernier","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2007.02.038_bib390","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1016\/j.bmc.2005.04.030","article-title":"New selective acetylcholinesterase inhibitors designed from natural piperidine alkaloids","volume":"13","author":"Viegas","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib391","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nbt0203-136","article-title":"Pseudomonas putida\u2014a versatile biocatalyst","volume":"21","author":"Wackett","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib392","series-title":"Biopharmaceuticals Biochemistry and Biotechnology","author":"Walsh","year":"2003"},{"key":"10.1016\/j.ejphar.2007.02.038_bib393","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1039\/b508634e","article-title":"Enantioselective synthesis of (+)(R)- and (\u2212)(S)-nicotine based on Ir-catalysed allylic amination","volume":"21","author":"Walter","year":"2005","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib394","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.brainresrev.2004.09.003","article-title":"Desensitized nicotinic receptors in brain","volume":"48","author":"Wang","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib395","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"\u03b2-Amyloid(1\u201342) binds to \u03b17 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib396","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1046\/j.1471-4159.2000.0751155.x","article-title":"Amyloid peptide A\u03b21-42 binds selectively and with picomolar affinity to \u03b17 nicotinic acetylcholine receptors","volume":"75","author":"Wang","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib397","first-page":"1867","article-title":"The Society for Research in Nicotine and Tobacco an amazing success story","volume":"96","author":"West","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2007.02.038_bib398","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/bmj.325.7357.174","article-title":"Banning smoking in the workplace","volume":"325","author":"West","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2007.02.038_bib399","first-page":"1","article-title":"The deadly weed. Nicotine and tobacco dependence","author":"West","year":"2002","journal-title":"Biochemist"},{"key":"10.1016\/j.ejphar.2007.02.038_bib400","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF02064991","article-title":"In vitro free radical production in rat esophageal mucosa induced by nicotine","volume":"40","author":"Wetscher","year":"1995","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib401","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0891-5849(94)00221-5","article-title":"Free radical production in nicotine treated pancreatic tissue","volume":"18","author":"Wetscher","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2007.02.038_bib402","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-1999-14-503","article-title":"Nicotinic acetylcholine receptors in Alzheimer's disease","volume":"1","author":"Wevers","year":"1999","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.ejphar.2007.02.038_bib403","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/ie50506a017","article-title":"Alkaloids of tobacco identification and determination","volume":"44","author":"Willaman","year":"1952","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib404","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1046\/j.1528-1157.2003.58102.x-i1","article-title":"Nicotine as an antiepileptic agent in ADNFLE: an N-of-one study","volume":"44","author":"Willoughby","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2007.02.038_bib405","series-title":"Free Radicals and Inflammation","author":"Winyard","year":"2000"},{"key":"10.1016\/j.ejphar.2007.02.038_bib406","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/tx0497696","article-title":"Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N\u2032-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine","volume":"18","author":"Wong","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib407","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0165-6147(90)90242-Z","article-title":"The paradox of nicotinic acetylcholine receptor upregulation by nicotine","volume":"11","author":"Wonnacott","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib408","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/jf00059a017","article-title":"13C CPMAS NMR of bright and burley tobaccos","volume":"43","author":"Wooten","year":"1995","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib409","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0021-9673(98)00223-4","article-title":"Analytical determination of nicotine in tobacco by supercritical fluid chromatography\u2013ion mobility detection","volume":"811","author":"Wu","year":"1998","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.ejphar.2007.02.038_bib410","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1021\/ac020291p","article-title":"Determination of nicotine and other minor alkaloids in international cigarettes by solid-phase microextraction and gas chromatography\/mass spectrometry","author":"Wu","year":"2002","journal-title":"Anal. Chem"},{"key":"10.1016\/j.ejphar.2007.02.038_bib411","doi-asserted-by":"crossref","first-page":"32405","DOI":"10.1074\/jbc.M504664200","article-title":"Investigating the receptor-independent neuroprotective mechanisms of nicotine in mitochondria","volume":"280","author":"Xie","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib412","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0169-409X(02)00065-0","article-title":"CYP2A6 genetic variation and potential consequences","volume":"54","author":"Xu","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2007.02.038_bib414","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejps.2004.04.012","article-title":"Metabolic profile of nicotine in subjects whose CYP2A6 gene is deleted","volume":"22","author":"Yamanaka","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2007.02.038_bib413","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/dmd.104.001701","article-title":"Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes","volume":"33","author":"Yamanaka","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2007.02.038_bib415","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/carcin\/13.10.1789","article-title":"Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes","volume":"13","author":"Yamazaki","year":"1992","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2007.02.038_bib416","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00216-002-1380-1","article-title":"Determination of tobacco alkaloids by gas chromatography with nitrogen\u2013phosphorus detection","volume":"373","author":"Yang","year":"2002","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ejphar.2007.02.038_bib417","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.toxicon.2004.01.017","article-title":"Nicotine, its metabolism and an overview of its biological effects","volume":"43","author":"Yildiz","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.ejphar.2007.02.038_bib418","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0300-483X(98)00105-X","article-title":"Nicotine enantiomers and oxidative stress","volume":"130","author":"Yildiz","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib419","first-page":"813","article-title":"The toxicology of aluminum in the brain: a review","volume":"21","author":"Yokel","year":"2000","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2007.02.038_bib420","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2125.2002.01667.x","article-title":"Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism","volume":"54","author":"Yoshida","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib421","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0149-2918(01)80059-X","article-title":"Mecamylamine: new therapeutic uses and toxicity\/risk profile","volume":"23","author":"Young","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib422","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0009-9236(97)90099-0","article-title":"Cotinine effects on nicotine metabolism","volume":"61","author":"Zevin","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib425","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF00168533","article-title":"The competition of (\u2212)-[3H]nicotine binding by the enantiomers of nicotine, nornicotine and anatoxin-\u03b1 in membranes and solubilized preparations of different brain regions of rat","volume":"348","author":"Zhang","year":"1993","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.02.038_bib424","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0006-8993(94)90343-3","article-title":"Effects of chronic treatment with (+)- and (\u2212)-nicotine on nicotinic acetylcholine receptors and N-methyl-d-aspartate receptors in rat brain","volume":"644","author":"Zhang","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.02.038_bib423","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0022-3565(24)37261-1","article-title":"Mechanism of nicotine-induced relaxation in the porcine basilar artery","volume":"284","author":"Zhang","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib426","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1124\/jpet.102.033548","article-title":"Pharmacological properties of nicotinic acetylcholine receptors expressed by guinea pig small intestinal myenteric neurons","volume":"302","author":"Zhou","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.02.038_bib427","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1631\/jzus.2004.1528","article-title":"Comparison of volatile and semivolatile compounds from commercial cigarette by supercritical fluid extraction and simultaneous distillation extraction","volume":"5","author":"Zi-gang","year":"2004","journal-title":"J. Zhejiang Univ."},{"key":"10.1016\/j.ejphar.2007.02.038_bib428","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/carcin\/bgh120","article-title":"Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)","volume":"25","author":"Zimmerman","year":"2004","journal-title":"Carcinogenesis"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907002464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907002464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:08:56Z","timestamp":1757974136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907002464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":428,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0014299907002464"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.02.038","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}